TB Intensive Workshop

CE Accredited Live Activity
Date: April 30-May 3, 2024
Location:
Training Room
ICPH, 1st Floor West Wing
225 Warren Street
Newark, NJ 07103

Provided by Rutgers Health and the Global Tuberculosis Institute

COURSE DESCRIPTION & OVERALL GOAL
This workshop for clinicians provides comprehensive information on the application of principles for the diagnosis and treatment of TB, as well as the management of TB in special situations. The goal is to enhance healthcare provider knowledge and skills in the diagnosis, treatment, and management of TB, promote networking among providers and encourage providers to seek expert consult when needed. Topics include transmission and pathogenesis, testing for TB infection, treatment of TB infection, diagnosis and treatment of TB disease, drug resistance, TB-HIV co-infection, extrapulmonary TB, TB in children and adolescents, and key aspects of patient management. The format includes lectures, interactive discussions, and case studies.

AGENDA
Click here for the agenda.

WHO SHOULD ATTEND
The workshop is designed for physicians, nurses and healthcare professionals who are involved in the diagnosis and management of TB patients. Individuals who work in the following settings would benefit from attending this workshop:

  • TB Programs
  • Health Departments
  • Hospitals
  • Correctional Facilities
  • Long Term Care Facilities
  • Immigrant & Refugee Health
  • Community Health Centers / Federally Qualified Health Centers
  • College or University Health Services

WHY COURSE IS NEEDED
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important for healthcare providers to enhance skills in TB diagnosis, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

COURSE REQUIREMENTS
This course will build upon basic TB concepts. Prior to the course, it is recommended that participants review the CDC’s Core Curriculum on Tuberculosis: What the Clinician Should Know (Available at: http://www.cdc.gov/tb/education/corecurr/index.htm). In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire course, and complete an evaluation form. A post-course follow-up evaluation will be sent within 3 months of the course.

OBJECTIVES
Upon completion of this workshop, participants should be better able to:

  • Interpret epidemiologic trends to better screen and treat groups who are at high risk for tuberculosis.
  • Apply the latest advances for assessing risk, testing, and treating TB infection to prevent development of disease.
  • Implement recommendations for prompt diagnosis, appropriate treatment and effective management of tuberculosis disease.
  • List approaches for addressing clinical and social challenges in the management of patients with tuberculosis to achieve successful outcomes.

CONTINUING EDUCATION INFORMATION
Logo, company name  Description automatically generatedIn support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.”
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 23.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
CNE: This activity is awarded 23.75 ANCC contact hours. Nurses should only claim those contact hours actually spent participating in the activity.


DISCLOSURE DECLARATION
The relevant financial relationships of all individuals who affect the content of continuing education activities and any discussion of off-label/investigational uses will be disclosed to the audience at the time of the activity.

APPLICATION INFORMATION & FEE
This course requires an application process. Please click below to apply:
https://rutgers.ca1.qualtrics.com/jfe/form/SV_6R0auZ65nSiOoke
Please note that the fee for this course is $200 and payment must be received prior to the course. Breakfast and lunch will be provided.

Notification of acceptance and additional course information will be sent via email.

CANCELLATION AND REFUND INFORMATION
Please note that refunds will only be issued if registrants notify us of their cancellation by April 16. We will not be able to provide any refunds if registrants cancel after the deadline.
We reserve the right to modify the activity content, faculty and activities, and to cancel this activity, if necessary.

FUNDING DISCLOSURE
Funding for this course was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Priscilla Moreira at
pkm51@rutgers.edu.  

FACULTY


E. Jane Carter, MD
Professor of Medicine
Warren Alpert Medical School, Brown University

David Cennimo, MD
Assistant Professor
Rutgers New Jersey Medical School

Tegan Cullen, MPH
Training and Technical Assistance Specialist
Cicatelli Associates, Inc.

Tyrone Fernandes, MPH
Public Health Representative III
Rutgers Global Tuberculosis Institute

Henry Fraimow, MD
Assistant Professor of Medicine
Cooper Medical School of Rowan University

Jillian Knorr, MPH
City Research Scientist, Bureau of TB Control
New York City Department of Health and Mental Hygiene

Mitchel Jobble, MPH
State Refugee and Immigrant Health Coordinator
Tuberculosis Control Program       

CT Department of Public Health

Alfred Lardizabal, MD
Executive Director
Rutgers Global Tuberculosis Institute

Juliet Leonard, RN
Public Health Nurse Consultant
New Jersey Department of Health

Navaneeth Narayanan, PharmDMPH
Clinical Assistant Professor
Rutgers University, Ernest Mario School of Pharmacy

Diana Nilsen, MD
Director of Medical Affairs, Bureau of TB Control
New York City Department of Health and Mental Hygiene

Amee Patrawalla, MD
Medical Director
Rutgers Global Tuberculosis Institute

Abe (Tye) Thomas
TB Survivor/Patient Advocate
We are TB

Chris Vinnard, MD
Clinical Development Leader
Bill & Melinda Gates Medical Research Institute

Mark Wolman, MPH
TB Consultant
Rutgers Global Tuberculosis Institute

Shu-Hua Wang, MD, PharmD
Director
Research and Implementation Science Capacity and Community Health
The Ohio State University Global One Health Initiative

Ed Zuroweste, MD
Medical Consultant
Pennsylvania Department of Health

 

PLANNING COMMITTEE


Carolyn Bargman, RN-C, BSN
TB Nurse Consultant
Rutgers Global Tuberculosis Institute
 

Alicia Gomez, MPH
Health Educator
Rutgers Global Tuberculosis Institute

Anita Khilall, MPH - Activity Director
Program Director, Education & Training
Rutgers Global Tuberculosis Institute

Alfred Lardizabal, MD
Executive Director
Rutgers Global Tuberculosis Institute


Priscilla Moreira, MPH
Health Educator
Rutgers Global Tuberculosis Institute